Načítá se...

Blinatumomab consolidation and maintenance therapy in adults with relapsed/refractory B-precursor acute lymphoblastic leukemia

In a phase 3 clinical study of heavily pretreated adults with relapsed/refractory (R/R) acute lymphoblastic leukemia (ALL), overall survival (OS) following blinatumomab, a BiTE (bispecific T-cell engager) immunooncology therapy, was significantly improved vs chemotherapy following induction (cycles...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Blood Adv
Hlavní autoři: Rambaldi, Alessandro, Huguet, Francoise, Zak, Pavel, Cannell, Paul, Tran, Qui, Franklin, Janet, Topp, Max S.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Hematology 2020
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7160264/
https://ncbi.nlm.nih.gov/pubmed/32289160
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000874
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!